Thrombosis with thrombocytopenia syndrome (TTS) Archives

Clotting Risks Cause FDA to Restrict Use of J&J Vaccine

Adults 18 & Older, CDC, Emergency Use Authorization (EUA), FDA, Janssen, Janssen COVID-19 Vaccine (J&J), Johnson & Johnson, Novel Coronavirus, Therapeutics, Thrombosis with thrombocytopenia syndrome (TTS)

The Janssen COVID-19 vaccine is now limited to certain individuals ages 18 and up after the U.S. Food and Drug Administration downgraded its emergency use authorization.

May 6, 2022/by Andrew Humphreys

AstraZeneca finds small clot risk after 1st COVID shot, less after 2nd

AstraZeneca, Blood Clots, COVID-19 shots, COVID-19 Studies, COVID-19 Vaccinations, European Medicines Agency (EMA), Oxford University, Side Effects, The Lancet, Thrombosis with thrombocytopenia syndrome (TTS)

AstraZeneca’s Covid-19 vaccine carries a small extra risk of rare blood clots with low platelets after the first dose and no extra risk after the second, a study led and funded by the drugmaker showed on July 28, after worries over side effects.

July 28, 2021/by Andrew Humphreys